Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,121 INR | +3.42% | +6.16% | +56.97% |
Sales 2024 * | 8.45B 101M | Sales 2025 * | 10.78B 129M | Capitalization | 55B 660M |
---|---|---|---|---|---|
Net income 2024 * | 908M 10.9M | Net income 2025 * | 1.42B 17.06M | EV / Sales 2024 * | 6.39 x |
Net cash position 2024 * | 1.06B 12.67M | Net cash position 2025 * | 1.2B 14.36M | EV / Sales 2025 * | 4.99 x |
P/E ratio 2024 * |
60.1
x | P/E ratio 2025 * |
38.8
x | Employees | 838 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.03% |
Latest transcript on Orchid Pharma Limited
1 day | -0.74% | ||
1 week | +1.84% | ||
Current month | +3.78% | ||
1 month | +3.78% | ||
3 months | +52.09% | ||
6 months | +132.24% | ||
Current year | +52.19% |
Managers | Title | Age | Since |
---|---|---|---|
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 20-03-30 |
Director of Finance/CFO | - | 20-06-28 | |
Kapil Dayya
CMP | Compliance Officer | - | Dec. 15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 74 | 20-03-30 | |
Mridul Dhanuka
BRD | Director/Board Member | 42 | 20-03-30 |
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 20-03-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 1,121 | +3.42% | 22 843 |
24-04-26 | 1,084 | -0.74% | 63,987 |
24-04-25 | 1,092 | +2.57% | 52,477 |
24-04-24 | 1,065 | +0.84% | 44,385 |
24-04-23 | 1,056 | +0.25% | 59,388 |
Delayed Quote NSE India S.E., April 26, 2024 at 07:43 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+52.19% | 659M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- ORCHPHARMA Stock